Anil Nayyar
- Systematic review: hepatosplenic T‐cell lymphoma on biologic therapy for inflammatory bowel disease, including data from the Food and Drug Administration Adverse Event Reporting System
2020/01/28 by Eric D. Shah, Elliot S. Coburn, Anil Nayyar +3 · 1 citation